Kurt de Vlam

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

Christian Antoni, Gerald G. Krueger, Kurt de Vlam et al. · Annals of the Rheumatic Diseases · 2005 · 704 citations · Full text

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

Josef S Smolen, Monika Schöls, Jürgen Braun et al. · Annals of the Rheumatic Diseases · 2017 · 662 citations · Full text

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

Laure Gossec, Josef S Smolen, C. Gaujoux-Viala et al. · Annals of the Rheumatic Diseases · 2011 · 447 citations · Full text

A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

Laure Gossec, Maarten de Wit, Uta Kiltz et al. · Annals of the Rheumatic Diseases · 2014 · 402 citations · Full text

Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.

Anneke Spoorenberg, Désirée van der Heijde, E de Klerk et al. · PubMed · 1999 · 321 citations

Immunology, Diagnosis, Axial Spondyloarthritis +20